The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 748K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

190 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Benzothiazole derivatives and 7-aza-benzothiazole derivatives as janus kinase 2 inhibitors and uses thereofBDB
Dana-Farber Cancer Institute
Cyclic molecules as Bruton's tyrosine kinase inhibitorBDB
Minghui Pharmaceutical (Shanghai)
ANTAGONIST OF ADENOSINE RECEPTORSBDB
Adorx Therapeutics
COMPOUND FOR EGFR KINASE INHIBITOR, COMPOSITION, AND USE THEREOFBDB
Zhejiang University
Imidazo[1,2- a]pyrazine and Imidazo[1,2- a]pyridine Based Tyrosyl-DNA Phosphodiesterase I (TDP1) InhibitorsBDB
Department Of Health and Human Services
Weed control methods and related compositions and plantsBDB
Syngenta Crop Protection
RADIOFLUORINATED AGENTS FOR PET IMAGING SELECTIVELY TARGETING FIBROBLAST ACTIVATION PROTEINBDB
Tufts College
N-ACYLHYDRAZONE COMPOUNDS CAPABLE OF INHIBITING NAV 1.7 AND/OR NAV 1.8, PROCESSES FOR THE PREPARATION THEREOF, COMPOSITIONS, USES, METHODS FOR TREATMENT USING SAME AND KITSBDB
Eurofarma
FUSED TETRACYCLIC COMPOUND, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF IN MEDICINEBDB
Jiangsu Hengrui Pharmaceuticals
Methods for treating neurological symptoms associated with lysosomal storage diseasesBDB
Genzyme
PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORSBDB
King''s College London
Pyridine derivatives with c-linked cyclic substituents as cGAS inhibitorsBDB
Boehringer Ingelheim International
SMALL MOLECULE INHIBITORS OF KRAS G12D MUTANTBDB
Merck Sharp & Dohme
4'-THIONUCLEOSIDE ANALOGUES AND THEIR PHARMACEUTICAL USEBDB
Gilead Sciences
Methods and Compositions for Treating CancerBDB
Ohio Northern University
NUCLEOSIDE ANALOG AND USE THEREOFBDB
Shanghai Institute of Materia Medica
1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES AS BCL-2 INHIBITORS FOR THE TREATMENT OF NEOPLASTIC AND AUTOIMMUNE DISEASESBDB
Newave Pharmaceutical
Dizocilpine derivatives as peripheral NMDA receptor antagonistsBDB
Institut National De La Sante Et De La Recherche Medicale (Inserm
NOVEL TETRAZOLESBDB
Boehringer Ingelheim International
Heterocycle RMB39 ModulatorsBDB
Recursion Pharmaceuticals
BENZOPYRAZOLE INHIBITORS OF SARM1BDB
Disarm Therapeutics
Furin inhibitorsBDB
Glaxosmithkline Intellectual Property Development
Isoquinoline-steroid conjugates and uses thereofBDB
Aerie Pharmaceuticals
Pyridinone MK2 inhibitors and uses thereofBDB
Xinthera
Polycyclic compounds as allosteric SHP2 inhibitorsBDB
Revolution Medicines
Oxadiazaspiro compounds for the treatment of drug abuse and addictionBDB
Esteve Pharmaceuticals
Cyanoaryl-aniline compounds for treatment of dermal disordersBDB
Nflection Therapeutics
Bicyclic heterocycles as FGFR inhibitorsBDB
Incyte
2-(3′-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4′-bipyridin]-2′-yl)-7,7-dimethyl-7,8-dihydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one as a BTK inhibitorBDB
Hutchison Medipharma
6-6 fused bicyclic heteroaryl compounds and their use as LATS inhibitorsBDB
Novartis
Imidazolidin-2-one compounds as PRMT5 modulatorsBDB
Aurigene Discovery Technologies
Treatment of GVHDBDB
Kadmon
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameBDB
Hanmi Pharm.
Macrocyclic compounds that inhibit MCL-1 proteinBDB
Amgen
PCSK9 inhibitors and methods of use thereofBDB
Astrazeneca
Triazolopyrimidine compounds and uses thereofBDB
Novartis
Dynamin-1-like protein inhibitorsBDB
Mitobridge
Sting agonistsBDB
Venenum Biodesign
Inhibitors of NEK7 kinaseBDB
Halia Therapeutics
Fused pyrazine derivatives as A2A / A2B inhibitorsBDB
Incyte
Selective estrogen receptor degradersBDB
Eli Lilly
Macrocycle containing aminopyrazole and pyrimidine and pharmaceutical composition and use thereofBDB
Chia Tai Tianqing Pharmaceutical Group
Bicyclic ketone compounds and methods of use thereofBDB
Genentech
Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodiesBDB
Bayer Pharma Aktiengesellschaft
Heterocyclic compounds and uses thereofBDB
Infinity Pharmaceuticals
Thienopyridine carboxamides as ubiquitin-specific protease inhibitorsBDB
Valo Early Discovery
Combinations comprising substituted imidazo[1,5-a]pyrazinones as PDE1 inhibitorsBDB
H. Lundbeck
Substituted pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitorsBDB
Array Biopharma
Pyrimidine compounds and pharmaceutical compositions for preventing or treating cancers including the sameBDB
Hanmi Pharm.
Pet imaging agentsBDB
Novartis
Inhibitors of lysine specific demethylase-1BDB
Celgene Quanticel Research
Modulators of the 5-hydroxytryptamine receptor 7 and their method of useBDB
Temple University
5-HT2C receptor agonists and compositions and methods of useBDB
Arena Pharmaceuticals
Processes for preparing ATR inhibitorsBDB
Vertex Pharmaceuticals
Bicyclic inhibitors of histone deacetylaseBDB
Rodin Therapeutics
Alkynyl dihydroquinoline sulfonamide compoundsBDB
Amgen
STK4 inhibitors for treatment of hematologic malignanciesBDB
Dana-Farber Cancer Institute
Pyrrolidine derivativesBDB
Hoffmann-La Roche
2,3-dihydro-isoindole-1-one derivative as BTK kinase suppressant, and pharmaceutical composition including sameBDB
Crystalgenomics
Ingenol analogs, pharmaceutical compositions and methods of use thereofBDB
Glaxosmithkline Intellectual Property Development
Glycosidase inhibitorsBDB
Asceneuron
Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine and cosmeticsBDB
Galderma Research & Development
Quinolone derivatives as FGFR inhibitorsBDB
Principia Biopharma
PARG inhibitory compoundsBDB
Cancer Research Technology
Toll-like receptor 7 (TLR7) agonists having a heterobiaryl moiety, conjugates thereof, and methods and uses thereforBDB
Bristol-Myers Squibb
Oxazole orexin receptor antagonistsBDB
Merck Sharp & Dohme
Macrocyclic immunomodulatorsBDB
Chemocentryx
Biaryl kinase inhibitorsBDB
Bristol-Myers Squibb
Bicyclic heterocycles as FGFR4 inhibitorsBDB
Incyte
Materials and method for inhibiting replication protein A and uses thereofBDB
Indiana University Research and Technology
Pyridine derivativesBDB
Hoffmann-La Roche
Benzazepine dicarboxamide compoundsBDB
Hoffmann-La Roche
Pyrimidine FGFR4 inhibitorsBDB
Eisai R&D Management
Pyrimidodiazepinone compoundBDB
Kyowa Hakko Kirin
Inhibitors of c-fms kinaseBDB
Janssen Pharmaceutica
C5, C6 oxacyclic-fused thiazine dioxide compounds as BACE inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
Substituted pyridinone-pyridinyl compoundsBDB
Confluence Life Sciences
Aroyl thiourea derivativesBDB
University Court of The University of St Andrews
Synthesis and biological evaluation of polyhydroxy benzophenone as mushroom tyrosinase inhibitors.BDB
Sun Yat-Sen University
Green synthesis, inhibition studies of yeast a-glucosidase and molecular docking of pyrazolylpyridazine amines.BDB
University of The Punjab
Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsBDB
Bayer Intellectual Property
Heteroaryl alkyne compound and use thereofBDB
Nanjing Sanhome Pharmaceutical
IRE-1α inhibitorsBDB
Mannkind
2,5-Diaryloxadiazoles and their precursors as novel inhibitors of cathepsins B, H and L.BDB
Kurukshetra University
Curcumin analogues as zinc chelators and their usesBDB
The Research Foundation of State University of New York
Inhibition of HIV-1 Reverse Transcriptase Dimerization by Small Molecules.BDB
University of Siena
Inhibitors of phosphodiesterase 11 (PDE11)BDB
Boston College
1-phenyl-substituted heterocyclyl derivatives and their use as prostaglandin D2 receptor modulatorsBDB
Actelion Pharmaceuticals
Piperazinyl and piperidinyl ureas as modulators of fatty acid amide hydrolaseBDB
Janssen Pharmaceutica
Chrysophaentin analogs that inhibit FtsZ proteinBDB
The United States of America, As Represented By The Secretary, Department of Health and Human Services
Triazine derivative and pharmaceutical composition comprising the sameBDB
Shionogi
Indole or indazole derivative or salt thereofBDB
Taiho Pharmaceutical
Compounds for the treatment of neurodegenerative diseasesBDB
Proteotech
Inhibitor Fingerprinting of Rhomboid Proteases by Activity-Based Protein Profiling Reveals Inhibitor Selectivity and Rhomboid Autoprocessing.BDB
Technische Universität München
2′-substituted nucleoside derivatives and methods of use thereof for the treatment of viral diseasesBDB
Merck Sharp & Dohme
Substituted fused imidazoles and pyrazoles and use thereofBDB
Bayer Intellectual Property
Inhibitor recognition specificity of MERS-CoV papain-like protease may differ from that of SARS-CoV.BDB
University of Illinois At Chicago
Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.BDB
China Pharmaceutical University
Quinone reductase 2 is an adventitious target of protein kinase CK2 inhibitors TBBz (TBI) and DMAT.BDB
University of Western Ontario
Synthesis, in vitro evaluation and molecular docking studies of thiazole derivatives as new inhibitors of a-glucosidase.BDB
Hazara University
Synthesis of benzimidazole derivatives as potent ß-glucuronidase inhibitors.BDB
Universiti Teknologi Mara (Uitm)
Pyrrolopyridazine JAK3 inhibitors and their use for the treatment of inflammatory and autoimmune diseasesBDB
Bristol-Myers Squibb
Compound of a reverse-turn mimetic and a production method and use thereforBDB
Jw Pharmaceutical
Pyridopyrazine derivatives and their useBDB
Zentaris
Quinolinyl glucagon receptor modulatorsBDB
Pfizer
Selective glycosidase inhibitors and uses thereofBDB
TBA
Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compoundsBDB
Pfizer
N-substituted aminobenzocycloheptene, aminotetraline, aminoindane and phenalkylamine derivatives, pharmaceutical compositions containing them, and their use in therapyBDB
Abbvie
Substituted imidazopyridinyl compoundsBDB
Arqule
Azetidine and piperidine compounds useful as PDE10 inhibitorsBDB
Amgen
Sulfur-containing heterocyclic derivative having beta secretase inhibitory activityBDB
Shionogi
Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine MCH-1 antagonists, methods of making, and use thereofBDB
Albany Molecular Research
Aminodihydrothiazine derivativesBDB
Shionogi
KAT II inhibitorsBDB
Pfizer
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1BDB
Vitae Pharmaceuticals
Phenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as BACE-1 inhibitors, compositions, and their useBDB
Merck Sharp & Dohme
Conformationally restricted urea inhibitors of soluble epoxide hydrolaseBDB
University of California
Evaluation of 5-enolpyruvoylshikimate-3-phosphate synthase substrate and inhibitor binding by stopped-flow and equilibrium fluorescence measurements.BDB
Monsanto Agricultural
InhibitorsBDB
Probiodrug
Histone deacetylase inhibitorsBDB
Orchid Chemicals & Pharmaceuticals
Rational Optimization of Drug-Target Residence Time: Insights from Inhibitor Binding to the Staphylococcus aureus FabI Enzyme-Product Complex.BDB
Stony Brook University
Rational design of quinazoline-based irreversible inhibitors of human erythrocyte purine nucleoside phosphorylase.BDB
Arizona State University
Conformational Adaptation Drives Potent, Selective and Durable Inhibition of the Human Protein Methyltransferase DOT1L.BDB
Epizyme
Synthesis and inhibitory activity of ureidophosphonates, against acetylcholinesterase: pharmacological assay and molecular modeling.BDB
Institute For Advanced Studies In Basic Sciences (Iasbs)
Recognition of benztropine by the dopamine transporter (DAT) differs from that of the classical dopamine uptake inhibitors cocaine, methylphenidate, and mazindol as a function of a DAT transmembrane 1 aspartic acid residue.BDB
Duquesne University
The rabbit motilin receptor: molecular characterisation and pharmacology.BDB
Glaxosmithkline
In vitro inhibition of cytosolic carbonic anhydrases I and II by some new dihydroxycoumarin compounds.BDB
Balikesir University Science & Art Faculty
Binding of KRH-594, an antagonist of the angiotensin II type 1 receptor, to cloned human and rat angiotensin II receptors.BDB
Shinshu University
AF2 interaction with Ascaris suum body wall muscle membranes involves G-protein activation.BDB
Pharmacia
Characterization of the diarylether sulfonylester (-)-(R)-3-(2-hydroxymethylindanyl-4-oxy)phenyl-4,4,4-trifluoro-1-sulfonate (BAY 38-7271) as a potent cannabinoid receptor agonist with neuroprotective properties.BDB
Bayer
Extended radioligand binding profile of iloperidone: a broad spectrum dopamine/serotonin/norepinephrine receptor antagonist for the management of psychotic disorders.BDB
Novartis Pharma
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.BDB
Nih
Opioid binding profiles of new hydrazone, oxime, carbazone and semicarbazone derivatives of 14-alkoxymorphinans.BDB
Hungarian Academy of Sciences
Yeast hexokinase inhibitors designed from the 3-D enzyme structure rebuilding.BDB
Universite Paul Sabatier
Interactions of the novel antipsychotic aripiprazole (OPC-14597) with dopamine and serotonin receptor subtypes.BDB
University of North Carolina
Comparison of the structure-activity relationships of melatonin receptor agonists and antagonists: lengthening the N-acyl side-chain has differing effects on potency on Xenopus melanophores.BDB
King'S College London
Cloned human and rat galanin GALR3 receptors. Pharmacology and activation of G-protein inwardly rectifying K+ channels.BDB
Synaptic Pharmaceutical
 
Design and Synthesis of Potent Inhibitors of Glutamine SynthetaseBDB
Chevron Chemical
Heteroarylimino-4-thiazolidinones as inhibitors of cartilage degradation.BDB
University of Catania
Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.BDB
Eberhard Karls University of Tuebingen
In vitro and in vivo characterization of MDL 105,212A, a nonpeptide NK-1/NK-2 tachykinin receptor antagonist.BDB
Hoechst Marion Roussel
Characterization of cloned somatostatin receptors SSTR4 and SSTR5.BDB
University of Pennsylvania
SR 142801, the first potent non-peptide antagonist of the tachykinin NK3 receptor.BDB
Sanofi Recherche
Different binding affinities of NMDA receptor channel blockers in various brain regions--indication of NMDA receptor heterogeneity.BDB
Merz
Opioid binding properties of brain and peripheral tissues: evidence for heterogeneity in opioid ligand binding sites.BDB
Stanford University
The characterization of [3H]sulpiride binding sites in rat striatal membranes.BDB
St, Marianna University School of Medicine
Characterization of the binding of a morphine (mu) receptor-specific ligand: Tyr-Pro-NMePhe-D-Pro-NH2, [3H]-PL17.BDB
Burroughs Wellcome
McN-5652: a highly potent inhibitor of serotonin uptake.BDB
Mcneil Pharmaceutical
Molecular cloning and expression of a dopamine D2 receptor from human retina.BDB
National Institute of Neurological Disorders and Stroke
NMDA receptor agonists derived from ibotenic acid. Preparation, neuroexcitation and neurotoxicity.BDB
Royal Danish School of Pharmacy
Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1.BDB
University of Toronto
Characterization of 5-hydroxytryptamine1B receptors in rat spinal cord via [125I]iodocyanopindolol binding and inhibition of [3H]-5-hydroxytryptamine release.BDB
University of Texas
Human serotonin 1D receptor is encoded by a subfamily of two distinct genes: 5-HT1D alpha and 5-HT1D beta.BDB
Synaptic Pharmaceutical
Human gene S31 encodes the pharmacologically defined serotonin 5-hydroxytryptamine1E receptor.BDB
Synaptic Pharmaceutical
Antagonistic properties are shifted back to agonistic properties by further N-terminal shortening of pituitary adenylate-cyclase-activating peptides in human neuroblastoma NB-OK-1 cell membranes.BDB
UniversitÉ
Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.BDB
Ariad Pharmaceuticals
Histamine H1 receptors identified in mammalian brain membranes with [3H]mepyramine.BDB
TBA
Structure-guided development of efficacious antifungal agents targeting Candida glabrata dihydrofolate reductase.BDB
University of Connecticut
Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli.BDB
University of Tokyo
Covalent reactions of wortmannin under physiological conditions.BDB
Massachusetts General Hospital